SENSUS HEALTHCARE DL-01
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for tr… Read more
Market Cap & Net Worth: SENSUS HEALTHCARE DL-01 (5TX)
SENSUS HEALTHCARE DL-01 (F:5TX) has a market capitalization of $56.79 Million (€55.32 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #21516 globally and #2337 in its home market, demonstrating a -6.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SENSUS HEALTHCARE DL-01's stock price €3.36 by its total outstanding shares 16465036 (16.47 Million).
SENSUS HEALTHCARE DL-01 Market Cap History: 2020 to 2026
SENSUS HEALTHCARE DL-01's market capitalization history from 2020 to 2026. Data shows growth from $53.87 Million to $56.79 Million (7.33% CAGR).
SENSUS HEALTHCARE DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SENSUS HEALTHCARE DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5TX by Market Capitalization
Companies near SENSUS HEALTHCARE DL-01 in the global market cap rankings as of March 19, 2026.
Key companies related to SENSUS HEALTHCARE DL-01 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
SENSUS HEALTHCARE DL-01 Historical Marketcap From 2020 to 2026
Between 2020 and today, SENSUS HEALTHCARE DL-01's market cap moved from $53.87 Million to $ 56.79 Million, with a yearly change of 7.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €56.79 Million | +7.01% |
| 2025 | €53.07 Million | -54.49% |
| 2024 | €116.62 Million | +221.83% |
| 2023 | €36.24 Million | -69.15% |
| 2022 | €117.46 Million | +14.88% |
| 2021 | €102.25 Million | +89.80% |
| 2020 | €53.87 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SENSUS HEALTHCARE DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $56.79 Million USD |
| MoneyControl | $56.79 Million USD |
| MarketWatch | $56.79 Million USD |
| marketcap.company | $56.79 Million USD |
| Reuters | $56.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.